We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+35.27%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$23.7M
Cap. Flow
-$10.9M
Cap. Flow %
-7.21%
Top 10 Hldgs %
49.48%
Holding
78
New
25
Increased
14
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
AVAV icon
AeroVironment
AVAV
+$3.78M
2
AXGN icon
Axogen
AXGN
+$2.78M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$2.41M
4
DRRX
DURECT Corp
DRRX
+$2.36M
5
CUTR
Cutera, Inc.
CUTR
+$1.95M

Top Sells

Rank Stock Value
1
BEAT
BioTelemetry, Inc.
BEAT
+$7.34M
2
MSTR icon
Strategy Inc
MSTR
+$4.07M
3
RPRX
Repros Therapeutics Inc.
RPRX
+$3.69M
4
UI icon
Ubiquiti
UI
+$3.4M
5
COA
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
+$2.89M

Sector Composition

Rank Sector Weight
1 Healthcare 50.2%
2 Technology 28.6%
3 Communication Services 5.65%
4 Industrials 3.63%
5 Materials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALX icon
1
Calix
CALX
$2.37B
$12.2M 8.06%
957,806
-126,400
-12% -$1.55M
LSAK icon
2
Lesaka Technologies
LSAK
$391M
$10.2M 6.73%
848,766
-99,800
-11% -$901K
BEAT
3
DELISTED
BioTelemetry, Inc.
BEAT
$10M 6.64%
1,013,318
-932,354
-48% -$7.34M
MSTR icon
4
Strategy Inc
MSTR
$54.6B
$8.58M 5.67%
826,630
-418,000
-34% -$4.07M
BDSI
5
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8.01M 5.3%
1,474,906
– –
TLPH icon
6
Talphera
TLPH
$63.8M
$5.86M 3.88%
27,189
-9,456
-26% -$2.06M
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$5.59M 3.7%
619,604
+36,386
+6% +$270K
PKT
8
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$5.03M 3.33%
324,700
+51,700
+19% +$733K
MEET
9
DELISTED
The Meet Group, Inc. Common Stock
MEET
$4.7M 3.11%
2,595,039
+177,080
+7% +$310K
SANW
10
DELISTED
S&W Seed Co
SANW
$4.64M 3.07%
29,169
-2,963
-9% -$445K
SIGA icon
11
SIGA Technologies
SIGA
$220M
$4.46M 2.95%
1,167,185
-401,752
-26% -$1.38M
SRPT icon
12
Sarepta Therapeutics
SRPT
$2.28B
$4.22M 2.79%
89,400
+62,600
+234% +$2.41M
ARAY icon
13
Accuray
ARAY
$31.3M
$4.06M 2.69%
550,400
+202,634
+58% +$1.28M
AVAV icon
14
AeroVironment
AVAV
$7.74B
$3.9M 2.58%
+169,426
New +$3.78M
UI icon
15
Ubiquiti
UI
$35.9B
$3.73M 2.47%
111,063
-126,900
-53% -$3.4M
AXGN icon
16
Axogen
AXGN
$2.78B
$3.36M 2.22%
+755,728
New +$2.78M
PCYO icon
17
Pure Cycle
PCYO
$275M
$3.09M 2.04%
669,436
+98,052
+17% +$532K
CUTR
18
DELISTED
Cutera, Inc.
CUTR
$2.89M 1.91%
324,337
+206,337
+175% +$1.95M
SDEV
19
Stablecoin Development Corp
SDEV
$49.5M
$2.77M 1.83%
11
+4
+57% +$886K
DRRX
20
DELISTED
DURECT Corp
DRRX
$2.67M 1.76%
+198,952
New +$2.36M
CSII
21
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.64M 1.74%
131,541
-44,800
-25% -$933K
RPRX
22
DELISTED
Repros Therapeutics Inc.
RPRX
$2.5M 1.65%
93,300
-172,000
-65% -$3.69M
P
23
DELISTED
Pandora Media Inc
P
$2.44M 1.62%
97,200
+45,800
+89% +$938K
SRL icon
24
Scully Royalty
SRL
$88.9M
$2.39M 1.58%
57,000
– –
ARCT icon
25
Arcturus Therapeutics
ARCT
$460M
$2.09M 1.38%
+16,536
New +$1.47M
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Sophrosyne Capital held 78 positions worth $151M, up 19% from $128M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sophrosyne Capital withdrew a net $10.9M in Q3 2013, closing 12 positions and reducing 22 holdings. Its most notable exit was COASTAL CONTACTS INC COMMON SHARES (CANADA), an estimated $2.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in AeroVironment worth $3.9M.

  • Sophrosyne Capital's largest Q3 2013 buy was AeroVironment: 169,426 shares worth $3.9M.
  • Sophrosyne Capital added most to Sarepta Therapeutics in Q3 2013, an estimated $2.41M increase.
  • Sophrosyne Capital's biggest Q3 2013 reduction was BioTelemetry, Inc., cutting an estimated $7.34M.
  • Sophrosyne Capital fully exited COASTAL CONTACTS INC COMMON SHARES (CANADA) in Q3 2013, selling an estimated $2.89M.
  • Sophrosyne Capital's ten largest holdings make up 49% of its $151M portfolio in Q3 2013.
  • Sophrosyne Capital opened 25 new positions and closed 12 in Q3 2013.
  • Sophrosyne Capital's portfolio value rose 19% quarter-over-quarter to $151M.

Based on Sophrosyne Capital's 13F filing for Q3 2013, filed 14 Nov 2013.